IONQ
IonQ, Inc.
There isn't enough reported data to score IONQ yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
IONQ Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Weak | |
| Unavailable |
IONQ's revenue is currently healthy, and its profitability is stable, but its cash flow is weak. There isn't enough data to rate its balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
IONQ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 33x | $30.86 | — |
| Cheap | 86x | $80.61 | +161% |
| Fair | 126x | $119 | +285% |
| Expensive | 147x | $138 | +349% |
Historical ranges are pointers, not guarantees.
IONQ has the edge over LLY in the historical PE scenario, which offers more potential upside but is not a forecast.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
IONQ Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect IONQ's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
IONQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.94 | +$6.31 |
| Q2 2026 | -$3.99 | -$1.96 |
| Q1 2026 | $0.39 | +$1.90 |
| Q4 2025 | -$1.82 | -$0.26 |
| Q3 2025 | -$5.37 | -$4.56 |
| Q2 2025 | -$2.03 | -$1.24 |
| Q1 2025 | -$1.51 | -$0.68 |
| Q4 2024 | -$1.56 | -$0.78 |
IONQ has returned to profit: it earned $0.94 per share over the past year, after losing money the year before.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over IONQ on earnings, with more consistent year-over-year improvement.
IONQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $173.8M | +336% |
| Q2 2026 | $80.1M | +287% |
| Q1 2026 | $64.7M | +755% |
| Q4 2025 | $61.9M | +429% |
| Q3 2025 | $39.9M | +222% |
| Q2 2025 | $20.7M | +82% |
| Q1 2025 | $7.6M | -0.2% |
| Q4 2024 | $11.7M | +92% |
IONQ's revenue is recovering but still below its 2022 peak: $174M last quarter, up 336% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -249% | +174 points |
| Q2 2026 | -421% | +355 points |
| Q1 2026 | -420% | +580 points |
| Q4 2025 | -369% | +292 points |
| Q3 2025 | -423% | +5.1 points |
| Q2 2025 | -776% | -346 points |
| Q1 2025 | -1000% | -303 points |
| Q4 2024 | -662% | +230 points |
IONQ's operating margin was −249% last quarter, up 174 points from the same quarter a year ago, near the top of its range since 2021.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over IONQ on profitability, with a higher operating margin.
IONQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$331.9M | -$204.7M |
| Q2 2026 | -$114M | -$60.2M |
| Q1 2026 | -$159.4M | -$124.1M |
| Q4 2025 | -$83.3M | -$40.3M |
| Q3 2025 | -$127.2M | -$104.2M |
| Q2 2025 | -$53.8M | -$19.7M |
| Q1 2025 | -$35.3M | -$11.7M |
| Q4 2024 | -$43M | -$9.2M |
IONQ has burned cash in almost every quarter: −$689M over the past year, against −$259M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over IONQ on cash generation, producing positive trailing cash flow while its opponent burns cash.
IONQ Net Leverage
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
IONQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.7 | Neutral |
| Stochastic | 22.3 | Neutral |
IONQ's weekly RSI is 41 (neutral) and its Stochastic is 22 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
IONQ PE vs Technology Sector
| Metric | IONQ | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 28x | 18% above |
IONQ has the edge over LLY on valuation relative to its sector.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
IONQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.7 | 13% below |
| 20 week MA | $38.6 | 20% below |
| 50 week MA | $42.4 | 27% below |
| 100 week MA | $42.2 | 27% below |
| 200 week MA | $26.8 | 15% above |
IONQ has fallen below most of its moving averages, though it's still 15% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over IONQ on trend strength, trading above more of its moving averages.
IONQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $11.0 | $17.9 | +62% |
| 2022 | $17.9 | $3.30 | -82% |
| 2023 | $3.30 | $12.4 | +275% |
| 2024 | $12.4 | $45.5 | +267% |
| 2025 | $45.5 | $46.0 | +1.1% |
| 2026 YTD | $46.0 | $30.9 | -33% |
IONQ's yearly returns have swung widely, from +275% in 2023 to −82% in 2022. It's down 33% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over IONQ on returns for 2026, with the stronger performance.